FindTrial
Sign In

The change of glycemic and lipid metabolism and endocrine function in patients with obstructive sleep apnea hypopnea syndrome and type 2 diabetes

The change of glycemic and lipid metabolism and endocrine function in patients with obstructive sleep apnea hypopnea syndrome and type 2 diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900023467
Enrollment
Unknown
Registered
2019-05-30
Start date
2019-10-01
Completion date
Unknown
Last updated
2019-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

patients with obstructive sleep apnea hypopnea syndrome:No intervention

Sponsors

Peking Univeristy International Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Type 2 diabetes.

Exclusion criteria

Exclusion criteria: sinusitis, nasal polyp, deviation of nasal septum, hypertrophy of tonsil, tonsillar hypertrophy, lymphatic tissue hyperplasia at the root of tongue, some patients with endocrine diseases such as hypothyroidism, acromegaly, adrenal cortex hyperplasia, and patients taking drugs affecting insulin sensitivity.

Design outcomes

Primary

MeasureTime frame
glucose;insulin;—

Countries

China

Contacts

Public ContactZhao Xin

Peking Univeristy International Hospital

zhaoxin2012@aliyun.com+86 18742404246

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026